Two co-founders to retire from Treace Medical board; director reclassified

TREACE MEDICAL CONCEPTS, INC.

F. Barry Bays and Thomas Timbie will retire from the Board at the 2023 annual meeting and not stand for re-election.
Both have served since the company's founding in June 2014; retirements not due to any disagreement.
Director Jane E. Kiernan reclassified as Class II director effective immediately before the 2023 annual meeting.
Kiernan will stand for election as a Class II director at the 2023 annual meeting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Thomas Timbie

Director

TMCI · TREACE MEDICAL CONCEPTS, INC.

Filed: February 23, 2023, 6:59 PM ET

On February 16, 2023, F. Barry Bays and Thomas Timbie provided notice to the board of directors (the “ Board ”) of Treace Medical Concepts, Inc. (the “ Company ”) of their intent to retire from the Board at the expiration of their current terms at the 2023 annual meeting of stockholders (the “ 2023 Annual Meeting ”) and not to stand for re-election.

Departed

F. Barry Bays

Director

TMCI · TREACE MEDICAL CONCEPTS, INC.

Filed: February 23, 2023, 6:59 PM ET

On February 16, 2023, F. Barry Bays and Thomas Timbie provided notice to the board of directors (the “ Board ”) of Treace Medical Concepts, Inc. (the “ Company ”) of their intent to retire from the Board at the expiration of their current terms at the 2023 annual meeting of stockholders (the “ 2023 Annual Meeting ”) and not to stand for re-election.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas Timbie departed as Director at TREACE MEDICAL CONCEPTS, INC..

Action: retire
Role: Director

Exact text from the filing

On February 16, 2023, F. Barry Bays and Thomas Timbie provided notice to the board of directors (the “ Board ”) of Treace Medical Concepts, Inc. (the “ Company ”) of their intent to retire from the Board at the expiration of their current terms at the 2023 annual meeting of stockholders (the “ 2023 Annual Meeting ”) and not to stand for re-election.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

F. Barry Bays departed as Director at TREACE MEDICAL CONCEPTS, INC..

Action: retire
Role: Director

Exact text from the filing

On February 16, 2023, F. Barry Bays and Thomas Timbie provided notice to the board of directors (the “ Board ”) of Treace Medical Concepts, Inc. (the “ Company ”) of their intent to retire from the Board at the expiration of their current terms at the 2023 annual meeting of stockholders (the “ 2023 Annual Meeting ”) and not to stand for re-election.

View on SEC.gov

TREACE MEDICAL CONCEPTS, INC. filing history →

Source: SEC EDGAR

accession 0000950170-23-004148

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.